Literature DB >> 33422618

The nAChR Chaperone TMEM35a (NACHO) Contributes to the Development of Hyperalgesia in Mice.

Sergey G Khasabov1, Victoria M Rogness1, Montana B Beeson2, Lucy Vulchanova3, Li-Lian Yuan4, Donald A Simone1, Phu V Tran5.   

Abstract

Pain is a major health problem, affecting over fifty million adults in the US alone, with significant economic cost in medical care and lost productivity. Despite evidence implicating nicotinic acetylcholine receptors (nAChRs) in pathological pain, their specific contribution to pain processing in the spinal cord remains unclear given their presence in both neuronal and non-neuronal cell types. Here we investigated if loss of neuronal-specific TMEM35a (NACHO), a novel chaperone for functional expression of the homomeric α7 and assembly of the heteromeric α3, α4, and α6-containing nAChRs, modulates pain in mice. Mice with tmem35a deletion exhibited thermal hyperalgesia and mechanical allodynia. Intrathecal administration of nicotine and the α7-specific agonist, PHA543613, produced analgesic responses to noxious heat and mechanical stimuli in tmem35a KO mice, respectively, suggesting residual expression of these receptors or off-target effects. Since NACHO is expressed only in neurons, these findings indicate that neuronal α7 nAChR in the spinal cord contributes to heat nociception. To further determine the molecular basis underlying the pain phenotype, we analyzed the spinal cord transcriptome. Compared to WT control, the spinal cord of tmem35a KO mice exhibited 72 differentially-expressed genes (DEGs). These DEGs were mapped onto functional gene networks using the knowledge-based database, Ingenuity Pathway Analysis, and suggests increased neuroinflammation as a potential contributing factor for the hyperalgesia in tmem35a KO mice. Collectively, these findings implicate a heightened inflammatory response in the absence of neuronal NACHO activity. Additional studies are needed to determine the precise mechanism by which NACHO in the spinal cord modulates pain.
Copyright © 2021 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  TMEM35a/NACHO; inflammation; nicotinic acetylcholine receptor; pain; spinal transcriptome

Mesh:

Substances:

Year:  2021        PMID: 33422618      PMCID: PMC7897319          DOI: 10.1016/j.neuroscience.2020.12.027

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  100 in total

1.  Tonic nicotinic transmission enhances spinal GABAergic presynaptic release and the frequency of spontaneous network activity.

Authors:  Carlos Gonzalez-Islas; Miguel Angel Garcia-Bereguiain; Brendan O'Flaherty; Peter Wenner
Journal:  Dev Neurobiol       Date:  2015-06-23       Impact factor: 3.964

2.  Efficacy and safety of the α4β2 neuronal nicotinic receptor agonist ABT-894 in patients with diabetic peripheral neuropathic pain.

Authors:  Michael C Rowbotham; Armen Arslanian; Wolfram Nothaft; W Rachel Duan; Andrea E Best; Yili Pritchett; Qian Zhou; Brett R Stacey
Journal:  Pain       Date:  2012-03-03       Impact factor: 6.961

3.  The spinal cord as a major site for the antinociceptive action of nicotine in the rat.

Authors:  M D Aceto; R S Bagley; W L Dewey; T C Fu; B R Martin
Journal:  Neuropharmacology       Date:  1986-09       Impact factor: 5.250

4.  The transcription factor DeltaFosB is recruited by inflammatory pain.

Authors:  Oliva Erendira Luis-Delgado; Michel Barrot; Jean-Luc Rodeau; Paula G Ulery; Marie-José Freund-Mercier; François Lasbennes
Journal:  J Neurochem       Date:  2006-06-19       Impact factor: 5.372

5.  Deletion of novel protein TMEM35 alters stress-related functions and impairs long-term memory in mice.

Authors:  Bruce C Kennedy; Jiva G Dimova; Srikanth Dakoji; Li-Lian Yuan; Jonathan C Gewirtz; Phu V Tran
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-05-11       Impact factor: 3.619

6.  Hyperalgesia and sensitization of dorsal horn neurons following activation of NK-1 receptors in the rostral ventromedial medulla.

Authors:  Sergey G Khasabov; Patrick Malecha; Joseph Noack; Janneta Tabakov; Glenn J Giesler; Donald A Simone
Journal:  J Neurophysiol       Date:  2017-08-09       Impact factor: 2.714

7.  The antinociceptive effects of nicotinic partial agonists varenicline and sazetidine-A in murine acute and tonic pain models.

Authors:  Shakir D AlSharari; F Ivy Carroll; J Michael McIntosh; M Imad Damaj
Journal:  J Pharmacol Exp Ther       Date:  2012-06-07       Impact factor: 4.030

8.  Activation of the alpha7-nicotinic acetylcholine receptor reverses complete freund adjuvant-induced mechanical hyperalgesia in the rat via a central site of action.

Authors:  Stephen J Medhurst; Jon P Hatcher; Christopher J Hille; Sharon Bingham; Nick M Clayton; Andy Billinton; Iain P Chessell
Journal:  J Pain       Date:  2008-07       Impact factor: 5.820

9.  Tetrodotoxin-resistant fibres and spinal Fos expression: differences between input from muscle and skin.

Authors:  Jonas Tesarz; Ulrich Hoheisel; Siegfried Mense
Journal:  Exp Brain Res       Date:  2012-11-18       Impact factor: 1.972

10.  Inhibition of peripheral macrophages by nicotinic acetylcholine receptor agonists suppresses spinal microglial activation and neuropathic pain in mice with peripheral nerve injury.

Authors:  Norikazu Kiguchi; Daichi Kobayashi; Fumihiro Saika; Shinsuke Matsuzaki; Shiroh Kishioka
Journal:  J Neuroinflammation       Date:  2018-03-27       Impact factor: 8.322

View more
  2 in total

1.  Alternative Splicing Mechanisms Underlying Opioid-Induced Hyperalgesia.

Authors:  Pan Zhang; Olivia C Perez; Bruce R Southey; Jonathan V Sweedler; Amynah A Pradhan; Sandra L Rodriguez-Zas
Journal:  Genes (Basel)       Date:  2021-10-01       Impact factor: 4.141

Review 2.  Targeting α7 nicotinic acetylcholine receptors for chronic pain.

Authors:  Ya-Qun Zhou; Dai-Qiang Liu; Cheng Liu; Ai-Jun Xu; Yu-Ke Tian; Wei Mei; Xue-Bi Tian
Journal:  Front Mol Neurosci       Date:  2022-09-30       Impact factor: 6.261

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.